Healthy Clinical Trial - Probiotics on Stress-associated Gastrointestinal

Status Completed

Clinical Trial Summary

The purpose of this research study is to evaluate the effect of a daily supplement of probiotics (Lactobacillus gasseri KS-13, Bifidobacterium bifidum G9-1, Bifidobacterium longum MM-2) on stress-associated gastrointestinal function in university students during the time of semester exams.

Clinical Trial Description

In this randomized, double-blind, placebo-controlled study, undergraduate students planning to take a fall final exam will receive a daily probiotic combination, individual probiotic, or placebo for 6 weeks. Questionnaires will assess gastrointestinal symptoms, immune health, stress and stress management, quality of life, diet, adverse events, and compliance. In a subset of subjects, stool samples will be collected at baseline and at week 5 of the intervention (the week before final exams) to characterize microbial communities. ;

Study Design

Related Conditions & MeSH terms

Healthy

Clinical Trial Details

NCT number	NCT03056846
Study type	Interventional
Source	University of Florida
Contact
Status	Completed
Phase	N/A
Start date	September 5, 2017
Completion date	February 5, 2018

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT00001844` - Study of New Magnetic Resonance Methods
Completed	`NCT03160261` - Effect of Exenatide on Cortisol Secretion	Phase 4
Recruiting	`NCT02875301` - Investigating Gains in Neurocognition in an Intervention Trial of Exercise	Phase 3
Completed	`NCT03203824` - The Effects of Dark Chocolate (70% Cacao) on EEG Brain Waves in Vigorously Active Individuals	N/A
Recruiting	`NCT03114839` - Effect of Lactobacillus Casei Shirota on the Small Intestinal Microbiota (ROBIN)	N/A
Active, not recruiting	`NCT03224702` - First-in-Human Trial of Anti-ADAMTS-5 Nanobody in Healthy Volunteers	Phase 1
Completed	`NCT03259464` - This Study Tests BI 685509 in Healthy Chinese and Japanese Men; the Study Tests How Different Doses of BI 685509 Are Taken up in the Body and How Well They Are Tolerated	Phase 1
Completed	`NCT03309566` - Bioequivalence Study of Two Formulatiosns With the Asscociaton of Efavirenz, Emtricitabine and Tenofovir	Phase 4
Completed	`NCT00526916` - PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [C-11]PBR28	Phase 1
Completed	`NCT00527579` - PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [F-18]FB	Phase 1
Completed	`NCT03373162` - Functional Effects of Botox on the Brain Using MRS and fMRI	Phase 4
Recruiting	`NCT02509494` - Staged Phase 3 Study to Assess the Safety and Immunogenicity of Ebola Candidate Vaccines Ad26.ZEBOV and MVA-BN-Filo During Implementation of Stages 1 and 2	Phase 3
Terminated	`NCT02555085` - Single Ascending Doses of BIIB063 in Healthy Volunteers	Phase 1
Completed	`NCT03125018` - Accuracy of SpO2 for Noninvasive Pulse Oximeter Sensor (LNCS ADTX)	N/A
Completed	`NCT03124901` - Accuracy of Noninvasive Pulse Oximeter Measurement of Hemoglobin for Rainbow DCI Sensor	N/A
Completed	`NCT00004556` - The Effects of Dextroamphetamine on Brain Function
Not yet recruiting	`NCT03617861` - Effect of Secretin in Functional Dyspepsia and Healthy Subjects	Phase 1/Phase 2
Completed	`NCT00091533` - Neural Correlates of Observation of Tactile Stimulation in Healthy Subjects	N/A
Completed	`NCT00068926` - VRC 300: Screening of Healthy Volunteers for Clinical Trials of Investigational Vaccines to Prevent Infectious Diseases	N/A
Completed	`NCT03280173` - A Study Comparing the Amounts of 2 Different Forms of Tafamidis (PF06291826), Both With and Without Food, In the Blood	Phase 1

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Probiotics on Stress-associated Gastrointestinal Function in University Students — SAS

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms